Search Results 71-80 of 2427 for 2024embarking
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine ...
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C137 in ...
Personal health is often among the top New Year's resolutions each January. Beyond diet and exercise, Dr. John Presutti, a Mayo Clinic family medicine ...
A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.